HIGHLIGHTS
- who: Kefan Chen et al. from the Stanford University, United States have published the article: Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: The aim of this study was to pool immunosuppressant response rates and median time to recovery for patients with ILICI. Study eligibility was accessed independently by two authors using a quality appraisal tool that covers an 18-point checklist that evaluated the quality of selected studies that consisted of the following seven aspects: study objective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.